Cargando…
Global DNA Hypomethylation in Peripheral Blood Leukocytes as a Biomarker for Cancer Risk: A Meta-Analysis
BACKGROUND: Good biomarkers for early detection of cancer lead to better prognosis. However, harvesting tumor tissue is invasive and cannot be routinely performed. Global DNA methylation of peripheral blood leukocyte DNA was evaluated as a biomarker for cancer risk. METHODS: We performed a meta-anal...
Autores principales: | Woo, Hae Dong, Kim, Jeongseon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3324531/ https://www.ncbi.nlm.nih.gov/pubmed/22509334 http://dx.doi.org/10.1371/journal.pone.0034615 |
Ejemplares similares
-
Global DNA hypomethylation in leukocytes associated with glioma risk
por: Shen, Jie, et al.
Publicado: (2017) -
Association between global DNA hypomethylation in leukocytes and risk of breast cancer
por: Choi, Ji-Yeob, et al.
Publicado: (2009) -
The Degree of Global DNA Hypomethylation in Peripheral Blood Correlates with That in Matched Tumor Tissues in Several Neoplasia
por: Barciszewska, Anna-Maria, et al.
Publicado: (2014) -
The Prognostic Value of Global DNA Hypomethylation in Cancer: A Meta-Analysis
por: Li, Jinhui, et al.
Publicado: (2014) -
Blood leukocyte LINE-1 hypomethylation and oxidative stress in knee osteoarthritis
por: Teerawattanapong, Nipaporn, et al.
Publicado: (2019)